Medications and Conditions Contraindicated with Metformin
Metformin is contraindicated in patients with severe renal impairment (eGFR <30 mL/min/1.73 m²), acute or chronic metabolic acidosis including diabetic ketoacidosis, and hypersensitivity to metformin. 1
Absolute Contraindications
Renal Impairment
- Severe renal impairment (eGFR <30 mL/min/1.73 m²) is an absolute contraindication 1
- Initiation is not recommended when eGFR is 30-45 mL/min/1.73 m² 1
- If eGFR falls below 45 mL/min/1.73 m² during treatment, assess benefit-risk and consider discontinuation 1
- Metformin should be discontinued if eGFR falls below 30 mL/min/1.73 m² 1
- The KDIGO guidelines recommend reviewing metformin use at eGFR 30-44 mL/min/1.73 m² and discontinuing at eGFR <30 mL/min/1.73 m² 2
Metabolic Acidosis
- Acute or chronic metabolic acidosis, including diabetic ketoacidosis (with or without coma), is an absolute contraindication 1
Hepatic Impairment
- Metformin is not recommended in patients with hepatic impairment due to increased risk of lactic acidosis 1
- The EASL guidelines explicitly state metformin should not be used in decompensated cirrhosis 3
- Metformin should be avoided in patients with significant ALT elevation 3
- Known hepatic disease is a contraindication 2
Temporary Discontinuation Required
Iodinated Contrast Procedures
Discontinue metformin at the time of or prior to iodinated contrast imaging in specific high-risk patients: 1
- Patients with eGFR 30-60 mL/min/1.73 m²
- Patients with history of liver disease
- Patients with alcoholism
- Patients with heart failure
- Patients receiving intra-arterial iodinated contrast
Re-evaluate eGFR 48 hours after the procedure; restart metformin only if renal function is stable 1
The KDIGO guidelines recommend withdrawing potentially nephrotoxic agents before and after contrast procedures 2
Acute Illness and Hospitalization
- Temporarily discontinue metformin during: 2
- Procedures requiring iodinated contrast
- Hospitalizations
- Any acute illness associated with dehydration or hypoxemia
- Acute illness that may compromise renal or liver function
Conditions Requiring Caution
Cardiovascular Conditions
- Use with caution in patients with impaired cardiac function or heart failure due to increased lactic acidosis risk 2
- Hypoxemic conditions are contraindications 2
- Conditions causing decreased tissue perfusion or hemodynamic instability are contraindications 2
Other High-Risk Conditions
- Alcohol abuse is a contraindication 2
- Severe infections require temporary discontinuation 2
- Any condition that might lead to lactic acidosis is a contraindication 2
Important Clinical Considerations
Lactic Acidosis Risk
- The primary concern with metformin contraindications is the risk of lactic acidosis, though this risk is extremely low when used appropriately 2
- Metformin itself does not cause hypoglycemia when used as monotherapy 4
- The prognosis of lactic acidosis is mainly related to underlying hypoxic disease and comorbidities rather than metformin levels alone 5
Monitoring Requirements
- Assess renal function prior to initiation and periodically thereafter 1
- More frequent renal function assessment is needed in elderly patients 1
- Regular monitoring of liver function tests is essential in patients with known liver disease 3
Special Populations
- Elderly patients: Dose selection should be cautious, starting at the low end of the dosing range, with more frequent renal function assessment 1
- Pregnancy: No oral agents, including metformin, should be used during pregnancy 2
- Premenopausal women: Metformin may restore ovulation in anovulatory women, increasing risk of unintended pregnancy; provide preconception counseling 2, 1